Physician profile
Bert M Petersen
NPI 1750323267
$6,966.94
in general payments reported to CMS, 2019-2025
9 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.72 · 2021: $6,296 · 2022: $186 · 2023: $75.67 · 2024: $149 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $422.64 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $6,210.00 | 2021 | |
| Abbvie INC. | $410.87 | 2021-2025 | |
| Myriad Genetic Laboratories, INC. | $102.14 | 2022-2025 | Myrisk |
| Tactile Systems Technology INC | $85.31 | 2021-2024 | Flexitouch Plus, Entre Plus |
| Coopersurgical, INC. | $53.39 | 2021-2025 | Paragard T 380a |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Elucent Medical | $24.75 | 2025 | |
| Sobi, INC | $18.72 | 2019 | |
| Smith+Nephew, INC. | $18.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bert Petersen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.